PIK3CA mutations as a prognostic factor in patients with residual rectal cancer after neoadjuvant chemoradiotherapy

被引：0
|
作者：
Park, Jee Young [1 ]
机构：
[1] Kyungpook Natl Univ, Chilgok Hosp, Daegu, South Korea
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
710
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
    Deng, Ling
    Zhu, Xuehua
    Sun, Yun
    Wang, Jiemin
    Zhong, Xiaorong
    Li, Jiayuan
    Hu, Min
    Zheng, Hong
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 128 - 140
  • [32] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian breast cancer patients
    Woldesonbet, Zelalem Desalegn
    Yohannes, Meron
    Addissie, Adamu
    Abebe, Tamrat
    Kantelhardt, Eva Johanna
    Vetter, Martina
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [33] The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China
    Wu, Haibo
    Wang, Wei
    Du, Jun
    Li, Hong
    Wang, Huogang
    Huang, Liangliang
    Xiang, Hang
    Xie, Jing
    Liu, Xiaoli
    Li, Heng
    Lin, Wenchu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1473 - 1492
  • [34] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian Breast cancer patients
    Woldesonbet, Zelalem Desalegn
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [35] The prevalence of PIK3CA mutations in gastric and colon cancer
    Velho, S
    Oliveira, C
    Ferreira, A
    Ferreira, AC
    Suriano, G
    Schwartz, S
    Duval, A
    Carneiro, F
    Machado, JC
    Hamelin, R
    Seruca, R
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1649 - 1654
  • [36] PIK3CA MUTATIONS BUT NOT PIK3CA AMPLIFICATIONS ARE EARLY EVENTS IN THE ENDOMETRIAL CARCINOGENESIS
    Berg, A.
    Mjos, S.
    Kusonmano, K.
    Hoivik, E. A.
    Holst, F.
    Halle, M. K.
    Birkeland, E.
    Werner, H. M. J.
    Oyan, A. M.
    Petersen, K.
    Kalland, K.
    Akslen, L. A.
    Trovik, J.
    Wik, E.
    Kraksted, C.
    Salvesen, H. B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [37] The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients
    Hayama, Shouko
    Nakamura, Rikiya
    Ishige, Takayuki
    Sangai, Takafumi
    Sakakibara, Masahiro
    Fujimoto, Hiroshi
    Ishigami, Emi
    Masuda, Takahito
    Nakagawa, Ayako
    Teranaka, Ryotaro
    Ota, Satoshi
    Itoga, Sakae
    Yamamoto, Naohito
    Nagashima, Takeshi
    Otsuka, Masayuki
    BMC CANCER, 2023, 23 (01)
  • [38] The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients
    Shouko Hayama
    Rikiya Nakamura
    Takayuki Ishige
    Takafumi Sangai
    Masahiro Sakakibara
    Hiroshi Fujimoto
    Emi Ishigami
    Takahito Masuda
    Ayako Nakagawa
    Ryotaro Teranaka
    Satoshi Ota
    Sakae Itoga
    Naohito Yamamoto
    Takeshi Nagashima
    Masayuki Otsuka
    BMC Cancer, 23
  • [39] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [40] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
12345